MiMedx Group MDXG Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $159.77M+50.1% | $166.12M+59.1% | $142.08M+60.0% | $118.87M+72.2% | $106.43M+120% | ||
| $296.76M+24.7% | $307.35M+32.4% | $281.9M+22.5% | $255.09M+13.4% | $237.99M+8.2% | ||
| $26.23M+9.0% | $25.34M+6.4% | $26.5M+9.3% | $24.89M-0.7% | $24.07M-1.6% | ||
| $1.06M-6.9% | $1.22M+20.9% | $933K+19.5% | $1.08M+26.2% | $1.14M+0.6% | ||
| $4.22M-6.7% | $8.67M+1.0% | $6.23M-32.9% | $4.52M-54.4% | $4.53M-47.4% | ||
| $20.94M+13.8% | $15.45M+8.7% | $19.34M+36.3% | $19.29M+35.0% | $18.4M+25.1% | ||
| $8.29M+54.9% | $10.3M+31.5% | $4.25M+46.1% | $4.86M+20.7% | $5.35M-12.2% | ||
| $240.33M+20.1% | $277.47M+44.6% | $254.1M+47.6% | $220.88M+43.4% | $200.11M+44.1% | ||
| $4.76M-17.6% | $4.71M-20.7% | $5M-22.4% | $5.39M-21.0% | $5.77M-21.3% | ||
| $23.86M+9.1% | $23.5M+10.2% | $22.97M+8.0% | $22.43M+7.9% | $21.87M+6.9% | ||
| $28.62M+3.5% | $28.21M+3.5% | $27.98M+0.9% | $27.82M+0.8% | $27.64M-0.6% | ||
| $19.44M0.0% | $19.44M0.0% | $19.44M0.0% | $19.44M0.0% | $19.44M0.0% | ||
| $12.03M+22.5% | $13.12M+12.8% | $10.06M+3.7% | $10.95M+8.9% | $9.82M-6.9% | ||
| $92.77M-22.7% | $96.33M-26.5% | $105.04M-26.9% | $114.02M+0.9% | $120.07M+51.0% | ||
| $6.89M+557% | $7.27M+8.4% | $2.99M+153% | $990K-20.1% | $1.05M-16.2% | ||
| $308.68M+14.1% | $342.65M+29.8% | $318.99M+30.8% | $291.11M+26.5% | $270.42M+22.0% | ||
| $11.46M+29.3% | $14.53M+96.1% | $11.42M+64.9% | $8.5M+11.8% | $8.87M-8.5% | ||
| $14.52M-22.5% | $31.07M+31.3% | $27.65M+37.1% | $22.03M+24.8% | $18.74M+4.6% | ||
| $1.5M+33.3% | $1.5M+50.0% | $1.38M+37.5% | $1.25M+25.0% | $1.13M+12.5% | ||
| $44.55M+4.5% | $64.27M+40.9% | $57.68M+37.5% | $50.29M+25.7% | $42.62M+0.9% | ||
| $16.09M-8.2% | $16.47M-7.6% | $16.84M-6.5% | $17.21M-5.7% | $17.53M-5.0% | ||
| $5.1M-32.0% | $5.37M-27.2% | $5.52M+88.8% | $6.98M+79.9% | $7.49M+42.0% | ||
| $65.74M-2.8% | $86.11M+21.6% | $80.04M+27.3% | $74.49M+19.9% | $67.64M+2.6% | ||
| 250M0.0% | 250M+169,968% | 250M0.0% | 250M0.0% | 250M0.0% | ||
| $296.33M+3.3% | $299.08M+5.2% | $296.67M+6.1% | $291.1M+6.0% | $286.86M+2.5% | ||
| -$53.54M+36.4% | -$42.68M+53.2% | -$57.87M+41.4% | -$74.62M+30.1% | -$84.24M+32.3% | ||
| $242.94M+19.8% | $256.55M+32.9% | $238.95M+32.0% | $216.62M+28.9% | $202.78M+30.2% | ||
| $308.68M+14.1% | $342.65M+29.8% | $318.99M+30.8% | $291.11M+26.5% | $270.42M+22.0% | ||
| $9.54M+146% | $8.7M+178% | $5.42M+95.8% | $3.94M+20.6% | $3.87M+18.6% | ||
| $20.94M+13.8% | $15.45M+8.7% | $19.34M+36.3% | $19.29M+35.0% | $18.4M+25.1% | ||
| $8.29M+320% | $10.3M+31.5% | $3.08M+42.9% | $3.03M-2.3% | $1.97M-29.6% | ||
| $6.89M+557% | $7.27M+8.4% | $2.99M+153% | $990K-20.1% | $1.05M-16.2% | ||
| $24.83M+3.2% | $37.32M+70.3% | $31.62M+67.6% | $27.79M+49.1% | $24.06M+29.5% | ||
| $25.94M+2.5% | $38.36M+65.3% | $32.71M+60.6% | $28.87M+39.9% | $25.3M+23.0% | ||
| $24.13M-12.9% | $19.6M-30.8% | $21.65M-29.3% | $27.4M— | $27.69M— | ||
| $12.03M+22.5% | $13.12M+27.0% | $10.06M+3.7% | $10.95M+8.9% | $9.82M-6.9% | ||
| $13.14M+18.8% | $14.16M+21.8% | $11.15M-0.5% | $12.03M-0.2% | $11.06M-11.9% | ||
| $6.89M+557% | $7.27M+8.4% | $2.99M+153% | $990K-20.1% | $1.05M-16.2% | ||
| $4.76M-17.6% | $4.71M-20.7% | $5M-22.4% | $5.39M-21.0% | $5.77M-21.3% | ||
| $6.89M+557% | $7.27M+8.4% | $2.99M+153% | $990K-20.1% | $1.05M-16.2% | ||
| $14.52M-22.5% | $31.07M+31.3% | $27.65M+37.1% | $22.03M+24.8% | $18.74M+4.6% | ||
| $942K-45.3% | $2.44M+22.4% | $2.3M+152% | $1.77M+69.4% | $1.72M+58.8% | ||
| $11.01M+16.5% | $11.38M+26.3% | $12.83M+52.8% | $15.11M+62.8% | $9.45M+2.7% | ||
| $4.45M+19.0% | $5.39M+40.3% | $4.61M+46.2% | $4.19M+36.6% | $3.74M+26.6% | ||
| $11.01M+16.5% | $11.38M+26.3% | $12.83M+52.8% | $15.11M+62.8% | $9.45M+2.7% | ||
| $14.52M-22.5% | $31.07M+31.3% | $27.65M+37.1% | $22.03M+24.8% | $18.74M+4.6% | ||
| $6.05M+36.5% | $5.79M+28.5% | $4.42M+70.5% | $3.41M+64.8% | $4.44M+8.9% | ||
| $2.72M+125% | $978K+113% | $2.08M+176% | $1.97M+32.8% | $1.21M-2.3% | ||
| $17.59M-5.7% | $22.53M-9.3% | $18.21M-4.2% | $18.46M-4.1% | $18.66M-4.1% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 148.9M+0.9% | 148.1M+0.8% | 148.1M+0.8% | 147.9M+0.8% | 147.6M+0.1% | ||
| $149K+0.7% | $148K+0.7% | $148K+0.7% | $148K+0.7% | $148K0.0% | ||
| $2.72M+125% | $978K+113% | $2.08M+176% | $1.97M+32.8% | $1.21M-2.3% | ||
| $1.55M+35.6% | $1.13M-7.6% | $2.15M+19.2% | $1.73M+30.2% | $1.14M-17.2% | ||
| $9.54M+146% | $8.7M+178% | $5.42M+95.8% | $3.94M+20.6% | $3.87M+18.6% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $250M0.0% | $250M0.0% | $250M0.0% | $250M0.0% | $250M0.0% | ||
| $148.93M+0.9% | $148.09M+0.8% | $148.08M+0.8% | $147.92M+0.8% | $147.61M+0.1% | ||
| $148.93M+0.9% | $148.09M+0.8% | $148.08M+0.8% | $147.92M+0.8% | $147.61M+0.1% | ||
| $942K-45.3% | $2.44M+22.4% | $2.3M+152% | $1.77M+69.4% | $1.72M+58.8% | ||
| $12.8M-10.1% | $24.21M+109% | $21.56M+135% | $16.84M+96.1% | $14.23M+77.6% | ||
| $24.83M+3.2% | $37.32M+70.3% | $31.62M+67.6% | $27.79M+49.1% | $24.06M+29.5% | ||
| $25.94M+2.5% | $38.36M+65.3% | $32.71M+60.6% | $28.87M+39.9% | $25.3M+23.0% | ||
| $1.35M+338% | $1.45M-3.1% | $1.68M+241% | $973K+11.1% | $308K-73.6% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MiMedx Group's total assets?
- MiMedx Group (MDXG) holds $308.7M in total assets, up 14.1% year over year.
- How much debt does MiMedx Group have?
- MiMedx Group carries $17.6M in total debt against $242.9M of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does MiMedx Group have?
- MiMedx Group holds $159.8M in cash and equivalents.
- Can MiMedx Group cover its short-term obligations?
- Its current ratio is 5.39 — current assets exceed current liabilities.
- Where does MiMedx Group's balance sheet data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
